The US Food and Drug Administration has appointed George Francis Tidmarsh, MD, PhD, as director of the Center for Drug Evaluation and Research (CDER).

Cuts to Medicaid prompted by the One Big Beautiful Bill Act could lead to thousands of excess deaths each year.

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin.

The FDA has accepted for review the second resubmitted NDA for reproxalap for the treatment of the signs and symptoms of dry eye disease.

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...

Peripheral neuropathy (PN) risk factors seem to explain a higher prevalence of the disease among non-Hispanic Black individuals, but not among Hispanic individuals.

After 3 or 6 years of myopia control with dual-focus lenses, myopia progression and axial growth were similar to untreated myopic eyes.

Castor oil exposure significantly reduces survival of Demodex mites, offering a potential therapeutic benefit to patients with Demodex blepharitis.

Uveitis occurred among 15.7% of children with oJIA and was linked to younger age at arthritis onset and ANA positivity.

After years of legal battles and health concerns, Juul Labs has the go-ahead to sell some of its electronic cigarettes in the United States.

Cornea tattooing increases psychosocial functioning by treating depression and anxiety in patients with corneal leukoma.

An artificial intelligence (AI) model integrated into a retina tracker for diabetic retinopathy can achieve high accuracy while being resource-efficient.